Skip to content
etf.net

BMED

GradeCNew York Stock Exchange Arca

iShares Health Innovation Active ETF

Active Equity · IShares · Inception 2020-09-28

$34.77+0.13 (+0.38%)

As of Sep 23, 2026, 10:16 AM EDT

Intraday session: up, 5 prints from 34.64 to 34.77. Range 34.64 to 34.82. Use the arrow keys to read each point.$34.65$34.70$34.8010 AM12 PM2 PM4 PM
Expense ratio
0.77%
Fund size
$14M
1Y return
+31.1%
Yield · Last 12 months
0.23%
Holdings
55
Volume · 30D
0M sh
NAV per share
$34.59
52W range
low $25.79high $34.86

The ETF.net BMED Grade

C

42/ 100

Rank 23 of 35 in US Active Sector⁠

Confidence High

Six-pillar profile for BMED. Scores out of 100: Cost 32, Risk 58, Mission 78, Tradability 14, Holdings 83, Durability 59. Strongest: Holdings (83). Weakest: Tradability (14). Leans toward Holdings and Mission.
F< 25
D≥ 25
C≥ 40
B≥ 55
A≥ 70

Score 42 of 100 sits in the C band. Bands: A ≥ 70, B ≥ 55, C ≥ 40, D ≥ 25, F < 25; the scale skips E.

  • Cost

    What you pay to own it — the expense ratio plus trading frictions, ranked within its category.
    DScore 32
    Category rank24/35 · mid-pack

  • Mission

    How faithfully it does the job it claims — tracking its mandate or index with minimal slippage.
    AScore 78
    Category rank5/9 · mid-pack

  • Risk

    How violently it can move — volatility, drawdown depth, and downside capture versus its category.
    BScore 58
    Category rank10/35 · top 29%

  • Tradability

    How cheaply and easily you can get in and out — liquidity, spread, and premium/discount stability.
    FScore 14
    Category rank32/35 · bottom quartile

  • Holdings

    What it actually owns — the quality, breadth, and concentration of the underlying portfolio.
    AScore 83
    Category rank5/35 · top 14%

  • Durability

    Whether it will still be here — the fund’s assets, age, flows, and issuer staying power.
    BScore 59
    Category rank14/35 · top 40%

Graded as of Sep 22, 2026

Our read on BMED

ETF.net Research

CBlackRock's stock-picking take on healthcare's next act: roughly 60 innovative and emerging health companies, actively run rather than indexed. A niche sleeve, priced and traded like one.

Stated mandate

The Fund seeks to maximize total return through active investment in innovative and emerging healthcare companies.

Why people hold it

  1. 01Genuinely active, not an index in disguise: a concentrated book of about 60 names, picked under a mandate to seek total return from innovative and emerging healthcare companies.ishares.com
  2. 02The portfolio holds closely to its stated lane, staying in health innovation rather than drifting toward generic large-cap exposure.
  3. 03Trading since 2020, so there is a multi-year live record from the manager to judge, not a backtest.

Worth knowing

  1. 01At 0.77% a year, it costs more than the typical active US equity fund (median 0.65%). That is the price tag on a specialist stock-picking mandate.
  2. 02Small and thinly traded, so bid-ask spreads run wider and order books thinner than the household-name healthcare ETFs.
  3. 03This is a narrow sector sleeve, not broad-market exposure. Diversified active peers like DFAU (0.12%) and FELC (0.18%) cover the whole US market for a fraction of the fee.

BMED Holdings

As of Sep 22, 2026, 4:37 AM
Asset class
Stocks
Holdings
55
Top-10 weight
41%
Largest holding
GILD5.1%

Sectors

  • Health Care100.0%

Geography

  • United States86.00%
  • Switzerland5.87%
  • Netherlands2.05%
  • Denmark1.86%
  • United Kingdom1.53%
  • China1.38%
  • Ireland0.66%
  • Belgium0.66%
The fund’s holdings, weight-ordered — page 1 of 4.
#TickerCompanyWeight %SharesMarket valueIn ETFs
001GILDGILEAD SCIENCES5.13%4,627$695K482
002ABBVABBVIE4.74%2,431$642K511
003TMOTHERMO FISHER SCIENTIFIC INC4.34%902$588K369
004JNJJOHNSON & JOHNSON4.33%2,172$586K521
005MRNAMODERNA4.23%3,722$573K240
006EWEDWARDS LIFESCIENCES3.83%5,880$519K318
007IQVIQVIA HOLDINGS3.78%1,923$512K290
008DHRDANAHER3.61%2,307$489K327
009WATWATERS CORP3.58%1,150$485K277
010BIIBBIOGEN3.42%2,150$463K331
011VRTXVERTEX PHARMACEUTICALS3.32%884$449K417
012MRKMERCK & CO INC3.19%2,943$432K506
013MTDMETTLER TOLEDO3.12%304$423K269
014ROP.SWROCHE PS PAR AG2.73%853$369K196
015DXCMDEXCOM INC2.56%3,881$347K365

Showing 1–15 of 59 holdings

BMED Performance

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

BMED$13,114
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$11,723
Sep 22, 2025 to Sep 22, 2026. BMED $13,114. SPY $11,723. Use the arrow keys to read each point.$9,239$11,357$13,474Sep 2025Mar 2026Sep 2026

Sep 22, 2025 – Sep 22, 2026

Returns run to the Sep 22, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for BMED. Periods over one year show the average yearly return.
PeriodBMED
Year to date+14.6%
1 month+0.1%
3 months+21.3%
1 year+31.1%
3 years+15.4%per year
5 years+2.7%per year
10 yearsFund is under 10 years old—per year

As of the close, with distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for BMED
YearReturn barBMED
2026 YTD+14.6%
2025+21.8%
2024+1.6%
2023+5.7%
2022−19.7%
2021−4.0%
2020+19.0%

History from Oct 2, 2020

BMED in the news

ETF.net Research hasn’t filed on BMED yet — coverage lands here as it’s written.

BMED Dividends

Adds up every distribution paid per share over the last 12 months, divided by the last completed close. Distributions are counted by ex-date. Data through Sep 22, 2026.
0.23%Last 12 months
Payout per share
$0.08Last 12 months
Last payment
$0.08 per share
Paid on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Irregular

Distribution history

2023–2026

One bar per payment. 2 payments from 2023 to 2026 YTD. Dec 20, 2023 $0.0072; Jun 15, 2026 $0.08. Use the arrow keys to read each point.2023202420252026YTD
Ex-datePay dateAmount per share
Jun 15, 2026Jun 18, 2026$0.08
Dec 20, 2023Dec 27, 2023$0.0072

BMED Risk

How much the fund’s monthly returns vary, scaled to a year.
16.6%
Annualised · 36 months to Aug 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
0.50
vs 3-month T-bills · to Aug 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−32.9%
Trough Sep 2022
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
0.74
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

BMED Cost

Expense ratio0.77%
  • The middle half of US Active Sector funds
  • Median 0.65%

21 of the 33 US Active Sector funds charge less.

BMED costs $77.00 a year on $10,000. The median US Active Sector fund costs $65.00.